The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Open accessAbstract
Parkinson's disease (PD) is a neurodegenerative disorder of uncertain pathogenesis characterized by the loss of the nigrostriatal dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Increased expression of cyclooxygenase type 2 (COX-2) and production of prostaglandin E 2 have been implicated in neurodegeneration in several pathological settings. Here we show that COX-2, the rate-limiting enzyme in prostaglandin E 2 synthesis, is up-regulated in brain dopaminergic neurons of both PD and MPTP mice. COX-2 induction occurs through a JNK/c-Jun-dependent mechanism after MPTP administration. We demonstrate that targeting COX-2 does not protect against MPTP-induced dopaminergic neurodegeneration by mitigating inflammation. Instead, we provide evidence that COX-2 inhibition prevents the formation of the oxidant species dopamine-quinone, which has been implicated in the pathogenesis of PD. This study supports a critical role for COX-2 in both the pathogenesis and selectivity of the PD neurodegenerative process. Because of the safety record of the COX-2 inhibitors, and their ability to penetrate the blood–brain barrier, these drugs may be therapies for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Self-citationCyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage
Nogawa, S., Zhang, F., Ross, M. E., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02746.1997 · Cited by 716
Przedborski, S., Jackson‐Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507
Self-citationProstaglandin and thromboxane biosynthesis
Smith, W. L., Marnett, L. J., & DeWitt, D. L. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90054-p · Cited by 442
Cyclooxygenase-2: Molecular Biology, Pharmacology, and Neurobiology
O'Banion, M. K. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i1.30 · Cited by 404
Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase
Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359
Spencer, A. G., Woods, J. W., Arakawa, T., Singer, I. I., & Smith, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9886 · Cited by 334
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
Self-citationThe parkinsonian toxin MPTP: action and mechanism
Przedborski, S., Jackson-Lewis, V., Djaldetti, R., Liberatore, G., Vila, M., Vukosavic, S., & Almer, G. (2000) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2000-00132 · Cited by 252
Self-citationLouis, E. D., Mayer, S. A., & Rowland, L. P. (2001) · Cited by 243
Saporito, M. S., Thomas, B. A., & Scott, R. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751200.x · Cited by 232
Age-Dependent Cognitive Deficits and Neuronal Apoptosis in Cyclooxygenase-2 Transgenic Mice
Andreasson, K. I., Savonenko, A., Vidensky, S., Goellner, J. J., Zhang, Y., Shaffer, A., Kaufmann, W. E., Worley, P. F., Isakson, P., & Markowska, A. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08198.2001 · Cited by 231
Ceramide Regulates the Transcription of Cyclooxygenase-2
Subbaramaiah, K., Chung, W. J., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32943 · Cited by 201
Kuhn, D. M., Arthur, R. E., Thomas, D. M., & Elferink, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731309.x · Cited by 183
Feng, Z.-H., Wang, T.-G., Li, D.-D., Fung, P., Wilson, B. C., Liu, B., Ali, S. F., Langenbach, R., & Hong, J.-S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00704-8 · Cited by 160
LaVoie, M. J., & Hastings, T. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732546.x · Cited by 150
Overexpression of Cyclooxygenase-2 Induces Cell Cycle Arrest
Trifan, O. C., Smith, R. M., Thompson, B. D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34141 · Cited by 114
Role of Cyclooxygenase-2 in Neuronal Cell Cycle Activity and Glutamate-Mediated Excitotoxicity
Mirjany, M., Ho, L., & Pasinetti, G. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.494 · Cited by 109
Mixed lineage kinase activity of indolocarbazole analogues
Murakata, C., Kaneko, M., Gessner, G. W., Angeles, T. S., Ator, M. A., O’Kane, T. M., McKenna, B. A., Thomas, B. A., Mathiasen, J. R., Saporito, M. S., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00690-4 · Cited by 93
Free Radicals in Brain Pathophysiology
Poli, G. (2000) · CRC Press eBooks · doi:10.1201/9781482270167 · Cited by 73
Ibuprofen, inflammation and Alzheimer disease
Wyss‐Coray, T., & Mucke, L. (2000) · Nature Medicine · doi:10.1038/79661 · Cited by 61
Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt, M. V., Heikkila, R. E., & Nicklas, W. J. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39184-6 · Cited by 32
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Cited by
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Self-citationTansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Metadata
- Authors
- Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-04-17
- Volume
- 100
- Issue
- 9
- Pages
- 5473-5478
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2056546282
- Cited by
- 660
- References
- 27
- FWCI
- 26.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.